Home > News > Bilcare buys Singapore's Singular ID for S$20m
January 4th, 2008
Bilcare buys Singapore's Singular ID for S$20m
Bilcare has acquired Singapore-based Singular ID for 20 million Singapore dollars, reports CNBC-TV18. The latter provides pharma counterfeit solutions.
Bilcare has been looking at advancing its technology, in terms of solutions for counterfeit drugs. Now, it has gone ahead and acquired a Singapore-based company called Singular ID. They had been looking at this particular company for sometime.
Singular ID is a very high technology company, which uses nanotechnology, in terms of developing solutions to minimize the use of counterfeit drugs, which is seen as a big menace for most of the pharmaceutical companies.
Law enforcement/Anti-Counterfeiting/Security/Loss prevention
New approach to microlasers: Technique for 'phase locking' arrays of tiny lasers could lead to terahertz security scanners June 17th, 2016
Leti Innovation Day in Lyon Will Explore New Security Challenges and Responses for a Safe Connected World June 15th, 2016
A better hologram for fraud protection and wearable optics: Nanotechnology improves holographic capabilities by encoding light polarization May 16th, 2016
Russian scientists develop long-range secure quantum communication system April 13th, 2016
How cancer cells spread and squeeze through tiny blood vessels (video) June 30th, 2016
Oxford Instruments and Dresden High Magnetic Field Laboratory collaborate to develop HTS magnet technology components for high field superconducting magnet systems June 29th, 2016
Texas A&M Chemist Says Trapped Electrons To Blame For Lack Of Battery Efficiency: Forget mousetraps — today’s scientists will get the cheese if they manage to build a better battery June 28th, 2016
Building a smart cardiac patch: 'Bionic' cardiac patch could one day monitor and respond to cardiac problems June 28th, 2016
GLOBALFOUNDRIES Completes Acquisition of IBM Microelectronics Business: Transaction adds differentiating technologies, world-class technologists, and intellectual property July 1st, 2015
Entest BioMedical, Inc. in Discussions to Acquire Nanotechnology Delivery System for Cancer Therapy June 3rd, 2015
Evident Thermoelectrics Acquires GMZ Energy: Investment Accelerates Launch Of Evident's Thermoelectric Modules For Waste Heat May 20th, 2015
Keysight Technologies Begins Trading as Independent Company November 3rd, 2014